might attract takeover interest given its strong market position, cash and connections? |
Buy it while you can....... |
Trading update due in the coming days I would say........ |
If it stays at this price, a takeover in the next year looks inevitable........ |
Nice news......... |
Always struggles to maintain any gains this stock........ |
Just to let shareholders and prospective investors know that Diaceutics will be presenting on the MelloMonday webinar at 5pm today.
The programme for the evening is as follows:
5.00 pm Mello welcome followed by a Question & Answer session from Sosandar
5.30 pm Company presentation from Diaceutics
6.10 pm Company presentation from WiseAlpha
6.50 pm Mello BASH with Damian Cannon & Kevin Taylor featuring Ten Entertainment Group (TEG) and Barratt Developments (BDEV)
There will be over 500 investors attending and these are very popular shows with company presentations, fund manager and investor interviews, and panel sessions.
Tickets for today's event are FREE so make sure you tune in and take advantage! |
Diaceutics (DXRX) Full Year 2022 Results presentation - April 2023
Diaceutics CFO, Nick Roberts & CIO Ryan Keeling present full year results for the period ended 31 December 2022, which shows a strong trading performance with continued momentum driving strategic investment into 2023.
Watch the video here:
Listen to the podcast here: |
Diaceutics PLC posted Finals for FY22 this morning titled "Strong trading performance with continued momentum driving strategic investment into 2023." Revenues increased 40% to £19.5 million, a 26% increase on a constant currency basis and materially ahead of initial expectations.Gross profit increased by 37% to £16.7 million, EBITDA was £3.6 million (2021: £2.3 million) with an EBITDA margin of 18%, slightly ahead of the prior year (2021: 17%). The outook is solid with order books up to £16.9 million, while the balance sheet is also strong with cash and cash equivalents of £19.8 million. Valuation looks a little unhelpful with PS ratio at around 5.5x, the share price also lacks positive momentum. DXRX has a solid track record of topline growth but is a share to monitor for the time being...
...from WealthOraacle |
Business in fine shape, can try tp push back through the 120p level now the banking stuff sorted out....! |
Bit of nibbling ahead of results, should give us a real handle for the coming months.... |
Finals week after next should give next focus for investors....... |
$1 billion value business sounds good....... |
chrisdgb,
I've finally declared my position today after I picked up a sizeable position here
Lets get excited about the future |
Looking forward to the results to focus back on the business..... |
Well, that was sorted quickly.....! |
Let us hope this is swiftly sorted, irritating as story is strong.... |
Yes, as I mentioned I think 120p is the right short term level (got way oversold) and look to push through 200p in medium term.. |
Looks like you are on your own here chris. Good place to be when the market are still bidding for stock. |
Set the clock ticking for a US company bid........... |
Great to see the renewed interest here, let us hope we get some broker push as well.. |
Push back to 120p on renewed interest in the short term........ |
Looking really good here, some very interesting updates....... |
Still seem to be some nice chunky buyers for this one..... |
get rid of TD |
Register for streaming realtime charts, analysis tools, and prices.
Hot Features
Premium
